h
Let’s Work Together
arrosa@select.com

Meet Arrosa, the perfect theme to elevate your online presentation with.

Search here!

Articoli di Articoli

Over the last three decades, there has been special interest in developing drugs that mimic the characteristics of natural tears for use it in the treatment of several ocular surface disorders. Interestingly, the composition of blood plasma is very similar to tears. Therefore, different blood-derived products like autologous serum (AS) and plasma rich in growth factors (PRGF) have been developed for the treatment of diverse ocular pathologies.

The application of the counter-torque technique has been proposed as a conservative and atraumatic alternative for the explantation of nonmobile dental implants. The objective of this report is to assess the performance of this technique in a large number of patients.

  • Autore:
  • Eduardo Anitua
  • Ricardo Tejero
  • Francisco Romero-Gavilán
  • Andreia Cerqueira
  • Iñaki García-Arnáez
  • Cristina Martinez-Ramos
  • Seda Ozturan
  • Raul Izquierdo
  • Mikel Azkargorta
  • Félix Elortza
  • Mariló Gurruchaga
  • Isabel Goñi
  • Julio Suay

Calcium ions are used in the development of biomaterials for the promotion of coagulation, bone regeneration, and implant osseointegration. Upon implantation, the time-dependent release of calcium ions from titanium implant surfaces modifies the physicochemical characteristics at the implant-tissue interface and thus, the biological responses

  • Autore:
  • Eduardo Anitua
  • Fernando Kirchner
  • Isidro Milani
  • Alex Martinez
  • Nicolas Kirchner-Bossi
  • Roberto Prado
  • Sabino Padilla

Plasma rich in growth factors (PRGF) is a leukocyte-free platelet-rich plasma (PRP) that is an effective biological approach to tissue repair and has been demonstrated to significantly improve multiple conditions, including low back pain and degenerative disc pathology

There is increasing evidence regarding the wound healing potential of platelet-derived autologous by-products. We provide preliminary data regarding the use of a new plasma rich in growth factors-derived autologous topical ointment for the management of hard-to-heal wounds

  • Autore:
  • Eduardo Anitua
  • Ronald M Sánchez-Ávila
  • Edmar Uribe-Badillo
  • Carlos Fernández-Vega González
  • Francisco Muruzabal
  • Borja de la Sen-Corcuera
  • Begoña Baamonde
  • Luis M Quirós
  • Jesús Merayo-Lloves

This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers